文献速递关节外科

初次髋膝关节置换术后阿片类药物出院处方变化影响再开药率与吗啡毫克当量:两万例机构经验

Changes in opioid discharge prescriptions after primary total hip and total knee arthroplasty affect opioid refill rates and morphine milligram equivalents : an institutional experience of 20,000 patients.
PubMed 文献 · Bone Joint J · 2021-01-01

该研究回顾性分析19,428例初次全髋或全膝关节置换患者,分三个逐步减少出院阿片处方量(750、520、320 MME)的时期,评估90天再开药率与总MME。结果显示出院处方<400 MME不是再开药风险因素,膝关节置换再开药率增加约5%~6%,髋关节置换无显著增加,总MME显著减少。

要点

  • 出院阿片处方<400 MME不是再开药风险因素(全人群p=0.772,初用阿片者p=0.272)。
  • 单侧全膝、双侧全膝、双侧单髁置换再开药风险最高(HR分别为5.62、6.32、5.29,均p<0.001)。
  • 从P1到P3,上述三种膝关节术式再开药率增加约5%~6%(p<0.001),髋关节置换无显著增加。

核心结论

  • 减少出院阿片处方量使总MME显著降低,但多数膝关节置换术式再开药率增加约5%。
  • 膝关节置换目前出院阿片处方量可能已适中,髋关节置换或可进一步减少。

研究设计与样本

  • 按出院常规MME分为三个时期:P1(750 MME)、P2(520 MME)、P3(320 MME),分析90天再开药率与再开药MME。

主要发现

  • 出院处方<400 MME不是再开药风险因素(全人群p=0.772,初用阿片者p=0.272)。
  • 术式是再开药最显著风险因素:单侧全膝HR=5.62、双侧全膝HR=6.32、双侧单髁HR=5.29(均p<0.001)。
  • 上述三种膝关节术式从P1到P3再开药率增加约5%~6%(p<0.001),髋关节置换无显著增加。
  • 总MME从P1到P3显著降低(p<0.001),相当于减少近50万片5 mg羟考酮。

关键数值与推荐

  • 三个时期常规出院MME分别为750、520、320 MME。
  • 出院处方<400 MME不是再开药风险因素(全人群p=0.772,初用阿片者p=0.272)。
  • 单侧全膝、双侧全膝、双侧单髁置换再开药HR分别为5.62、6.32、5.29(均p<0.001)。
  • 膝关节置换再开药率从P1到P3增加约5%~6%(p<0.001)。

临床怎么用

  • 膝关节置换出院阿片处方量可维持在较低水平,进一步减少需谨慎评估再开药风险。
  • 髋关节置换出院阿片处方量或可进一步减少而不显著增加再开药率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Due to the opioid epidemic in the USA, our service progressively decreased the number of opioid tablets prescribed at discharge after primary hip (THA) and knee (TKA) arthroplasty. The goal of this study was to analyze the effect on total morphine milligram equivalents (MMEs) prescribed and post-discharge opioid repeat prescriptions. METHODS: We retrospectively reviewed 19,428 patients undergoing a primary THA or TKA between 1 February 2016 and 31 December 2019. Two reductions in the number of opioid tablets prescribed at discharge were implemented over this time; as such, we analyzed three periods (P1, P2, and P3) with different routine discharge MME (750, 520, and 320 MMEs, respectively). We investigated 90-day refill rates, refill MMEs, and whether discharge MMEs were associated with represcribing in a multivariate model. RESULTS: A discharge prescription of < 400 MMEs was not a risk factor for opioid represcribing in the entire population (p = 0.772) or in opioid-naïve patients alone (p = 0.272). Procedure type was the most significant risk factor for narcotic represcribing, with unilateral TKA (hazard ratio (HR) = 5.62), bilateral TKA (HR = 6.32), and bilateral unicompartmental knee arthroplasty (UKA) (HR = 5.29) (all p < 0.001) being the highest risk for refills. For these three procedures, there was approximately a 5% to 6% increase in refills from P1 to P3 (p < 0.001); however, there was no significant increase in refill rates after any hip arthroplasty procedures. Total MMEs prescribed were significantly reduced from P1 to P3 (p < 0.001), leading to the equivalent of nearly 500,000 fewer oxycodone 5 mg tablets prescribed. CONCLUSION: Decreasing opioids prescribed at discharge led to a statistically significant reduction in total MMEs prescribed. While the represcribing rate did not increase for any hip arthroplasty procedure, the overall refill rates increased by about 5% for most knee arthroplasty procedures. As such, we are now probably prescribing an appropriate amount of opioids at discharge for knee arthroplasty procedure, but further reductions may be possible for hip arthroplasty procedures. Cite this article: Bone Joint J 2021;103-B(7 Supple B):103-110.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Chalmers BP, Lebowitz J, Chiu YF, et al. Changes in opioid discharge prescriptions after primary total hip and total knee arthroplasty affect opioid refill rates and morphine milligram equivalents : an institutional experience of 20,000 patients. Bone Joint J. 2021. PMID: 34192916. doi:10.1302/0301-620X.103B7.BJJ-2020-2392.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。